Want more
What this means for the Indian market: Increased accessibility of Semaglutide therapy Greater competition leading to potential price rationalization Expansion of obesity management as a mainstream therapeutic segment A new strategic battleground for pharma marketing teams For healthcare professionals and the pharma industry, this could be one of the most competitive launches in the metabolic segment in the coming years
Please wait while we finish adding this item to your cart
Why are we talking about glutathione and The doctor that hired me told me oh, no, that's too hard to work with so let's just stick to vitamin C So I did his project but on the side
Methods We systematically searched PubMed, Embase, ClinicalKey, Cochrane CENTRAL, ProQuest, ScienceDirect, Web of Science, and ClinicalTrials.gov through October 24th, 2024, for randomized controlled trials (RCTs) of GLP-1 receptor agonists or SGLT2 inhibitors